AKT1 and neoplasm: In the pathway enrichment, the PI3K-Akt signaling pathway (hsa04151) has been identified as the critical target of tumor-targeted therapy, which plays a vital role in regulating the proliferation, migration, and apoptosis of tumor cells [75–77].